CAS
AGN

CTC Alternative Strategies’s Allergan Inc AGN Stock Holding History

CTC Alternative Strategies’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,100
Closed -$678K – 252
2013
Q4 		$678K Buy
+6,100
New +$583K 0.52% 23
2013
Q3 		– Sell
-3,200
Closed -$270K – 250
2013
Q2 		$270K Buy
+3,200
New +$332K 0.07% 127

Other funds holding AGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CTC Alternative Strategies's AGN Position: Q1 2014 in Review

CTC Alternative Strategies sold out of Allergan Inc (AGN) in Q1 2014, closing a stake of 6,100 shares — an estimated $678K sold.

CTC Alternative Strategies first reported a position in AGN in Q2 2013 and held it in 2 quarters. The position peaked at $678K in Q4 2013. 733 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

  • CTC Alternative Strategies reported no remaining Allergan Inc position as of Q1 2014 after selling out during the quarter.
  • CTC Alternative Strategies sold 6,100 Allergan Inc shares in Q1 2014, an estimated $678K.
  • CTC Alternative Strategies first reported a position in Allergan Inc in Q2 2013 and held it in 2 quarters.
  • CTC Alternative Strategies's Allergan Inc position peaked at $678K in Q4 2013.
  • 733 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2014.

Based on CTC Alternative Strategies's 13F filing for Q1 2014, filed 2 May 2014.